Role of β1- and β2-adrenoceptor polymorphisms in heart failure: A case-control study

European Heart Journal

Volumn 25, Issue 17, 2004, Pages 1534-1541

  Covolo, Loredana ^a   Gelatti, Umberto ^a   Metra, Marco ^a   Nodari, Savina ^a   Piccichè, Antonio ^a   Pezzali, Natalia ^a   Zani, Claudia ^a   Alberti, Adriana ^a   Donato, Francesco ^a   Nardi, Giuseppe ^a   Dei Cas, Livio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

1 adrenoceptor; 2 adrenoceptor; Case control study; Genetic polymorphism; Heart failure

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; CASE CONTROL STUDY; CONGESTIVE HEART FAILURE; GENE FREQUENCY; GENETICS; HOMOZYGOTE; MIDDLE AGED; RISK FACTOR;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HEART FAILURE, CONGESTIVE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS;

EID: 4444382138     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.06.015     Document Type: Article

References (40)

1. L. Wilhelmsen, A. Rosengren, and H. Eriksson Heart Failure in the general population of men - morbidity, risk factors and prognosis J. Inter. Med. 249 2001 253 261
2. W.B. Kannel Vital epidemiologic clues in heart failure J. Clin. Epidemiol. 53 2000 229 235
3. K.F. Adams New epidemiologic perspectives concerning mild-to-moderate heart failure Am. J. Med. 110 2001 6S 13S
4. S. Stewart, L. Blue, and A. Walker An economic analysis of specialist heart failure nurse management in the UK Eur. Heart J. 23 2002 1369 1378
5. L. Dei Cas, M. Metra, and S. Nodari Prevention and management of chronic heart failure in patients at risk Am. J. Cardiol. 91 9A 2003 10F 17F
6. M.R. Bristow Beta-adrenergic receptor blockade in chronic heart failure Circulation 101 2000 2877 2882
7. M. Metra, S. Nodari, and A. D'Aloia A rationale for the use of beta-blockers as standard treatment for heart failure Am. Heart J. 139 2000 511 521
8. K.M. Small, D.A. Rathz, and S.B. Liggett Identification of adrenergic receptor polymorphisms Methods Enzymol. 343 2002 459 475
9. A. Maqbool, A.S. Hall, and S.G. Ball Common polymorphisms of β1-adrenoceptor: identification and rapid screening assay Lancet 353 1999 897
10. D.A. Mason, J.D. Moore, and S.A. Green A gain-of-function polymorphism in a G-protein coupling domain of the human1-adrenergic receptor J. Biol. Chem. 274 1999 12670 12674
11. M. Bohm, M. Flesch, and P. Schnabel Beta-adrenergic signal transduction in the failing and hypertrophied myocardium J. Mol. Med. 75 1997 842 848
12. S.B. Liggett, L.E. Wagoner, and L.L. Craft The Ile 164 β2-adrenergic receptor polymorphisms adversely affects the outcome of congestive heart failure J. Clin. Invest. 102 1998 1534 1539
13. L.E. Wagoner, L.L. Craft, and B. Singh Polymorphisms of the β2-adrenergic receptor determine exercise capacity in patients with heart failure Circ. Res. 86 2000 834 840
14. 2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein Circulation 100 1999 2210 2212
15. S.B. Liggett, N.M. Tepe, and J.N. Lorenz Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level Circulation 101 2000 1707 1714
16. S.B. Liggett Polymorphisms of the β2-adrenergic receptor and asthma Am. J. Respir. Crit. Care Med. 156 1997 S156 S162
17. S.A. Green, J. Turki, and M. Innis Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 33 1994 9414 9419
18. V. Dishy, G. Sofowora, and H. Xie The effect of common polymorphisms of the β2-adrenergic receptor on agonist-mediated vascular desensitisation N. Engl. J. Med. 345 2001 1030 1035
19. H. Xie, C. Stein, and R. Kim Frequency of functionally important β-2 adrenonceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals Pharmacogenetics 9 1999 511 516
20. V. Large, L. Hellström, and S. Reynisdottir Human Beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte Beta-2 adrenoceptor function J. Clin. Invest. 100 1997 3005 3013
21. F. Tesson, P. Charron, and M. Peuchmaurd Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group J. Mol. Cell Cardiol. 31 1999 1025 1032
22. J.R. Cockcroft, A.G. Gazis, and D.J. Cross β2-adrenoceptor polymorphism determines vascular reactivity in humans Hypertension 36 2000 371 375
23. L.M. Humma, B.J. Puckett, and H.E. Richardson Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia Am. J. Cardiol. 88 2001 1034 1037
24. K. Bengtsson, O. Melander, and M. Orho-Melander Polymorphism in the β1-adrenergic receptor gene and hypertension Circulation 104 2001 187 190
25. H.L. White, R.A. de Boer, and A. Maqbool An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study Eur. J. Heart Fail. 5 2003 463 468
26. P.A. McKee, W.P. Castelli, and P.M. McNamara The natural history of congestive heart failure The New Engl. J. Med. 285 1971 1441 1446
27. W.J. Remme, and K. Swedberg Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure Eur. Heart J. 22 2001 1527 1560
28. K.J. Rothman, and S. Greeland Modern epidemiology second ed. 1998 Lippincott-Raven Publishers Philadelphia, PA p. 147-148
29. K.J. Rothman, and S. Greeland Modern epidemiology second ed. 1998 Lippincott-Raven Publishers Philadelphia, PA p. 191
30. R.J. Lefkowitz, H.A. Rockman, and W.J. Koch Catecholamines, cardiac β-adrenergic receptors, and heart failure Circulation 101 2000 1634 1637
31. K.M. O'Shaughnessy, B. Fu, and C. Dickerson The gain-of-function G389R variant of the β1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects Clin. Sci. 99 2000 233 238
32. R. Buscher, H. Belger, and K.J. Eilmes In-vivo studies do not support a major functional role for the Gly 389 Arg β1-adrenoceptor polymorphism in humans Pharmacogenetics 11 2001 199 205
33. J.M. Perez, D.A. Rathz, and N.N. Petrashevskaya beta(1)-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure Nat. Med. 9 2003 1300 1305
34. M. Borjesson, Y. Magnusson, and A. Hjalmarson A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure Eur. Heart J. 21 2000 1853 1858
35. L.E. Wagoner, L.L. Craft, and P. Zengel Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure Am. Heart J. 144 2002 840 846
36. S.M. Herrmann, V. Nicaud, and L. Tiret Polymorphisms of the beta2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies J. Hypertens. 20 2 2002 229 235
37. M. Castellano, F. Rossi, and M. Giacchà β2-adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes Hypertension 41 2003 361 367
38. M.S. Bray, J. Krushkal, and L. Li Positional genomic analysis identifies the β-2 adrenergic receptor gene as a susceptibility locus for human hypertension Circulation 101 2000 2877 2882
39. B. Timmermann, R. Mo, and F. Luft β2 adrenoreceptor genetic variation is associated with genetic predisposed essential hypertension: the Bergen Blood Pressure Study Kidney Int. 53 1998 1455 1460
40. S.B. Liggett Polymorphisms of the β2-adrenergic receptor New Engl. J. Med. 346 2002 536 567 (letter)